C Markopoulos, CJ Andreas, M Vertzoni… - European Journal of …, 2015 - Elsevier
Background Biorelevant media for evaluation of dosage form performance in the gastrointestinal lumen were first introduced in the late 1990s. Since then, a variety of …
D Shep, C Khanwelkar, P Gade, S Karad - Trials, 2019 - Springer
Background The purpose of this study was to compare the efficacy and safety of curcumin with those of diclofenac in the treatment of knee osteoarthritis (OA). Methods In this …
The focus of the current investigations was to apply quality by design (QbD) approach to the development of dispersible tablets. Critical material and process parameters are linked to …
GE Granero, MR Longhi, MJ Mora… - Journal of …, 2010 - Elsevier
Literature and new experimental data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate release (IR) solid oral dosage …
K Thelen, K Coboeken, S Willmann, R Burghaus… - Journal of …, 2011 - Elsevier
To enable more precise prediction of oral drug absorption, an existing physiologically based absorption model was revised. The revised model reflects detailed knowledge of human …
E Jantratid, V De Maio, E Ronda, V Mattavelli… - European Journal of …, 2009 - Elsevier
In vitro biorelevant dissolution tests enabling the prediction of in vivo performance of an oral modified-release (MR) dosage form were developed in this study. In vitro dissolution of MR …
AR Jesus, MRC Soromenho, LR Raposo… - European Journal of …, 2019 - Elsevier
The major challenge of the pharmaceutical industry is to find potential solvents for poorly water-soluble drug molecules. Ionic liquids (ILs) have attracted this industry as (co-) solvents …
S Cascone - European Journal of Pharmaceutical Sciences, 2017 - Elsevier
During the last decades, the study of the in vitro dissolution of pharmaceuticals has been strongly encouraged by the FDA in order to determine its relationship with the in vivo …
IE Shohin, JI Kulinich, GV Ramenskaya… - Journal of …, 2012 - Elsevier
Literature and experimental data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate‐release (IR) solid oral dosage …